Q78.1
Polyostotic fibrous dysplasia
Clinical Classification Guidelines
Inclusion Terms
- Albright(-McCune)(-Sternberg) syndrome
Medical Intelligence & Overview
Polyostotic fibrous dysplasia is a rare, non-cancerous bone disorder characterized by the replacement of normal bone with fibrous tissue, leading to weakened and deformed bones. This condition can affect multiple bones throughout the body and is often associated with specific syndromes such as Albright-McCune syndrome or Albright-Sternberg syndrome. Named after the physicians who first described it, fibrous dysplasia involves abnormal bone growth that can cause pain, deformity, and increased risk of fractures.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting bone development, primarily involving the GNAS gene. Post-zygotic mutations leading to mosaic distribution of affected cells. No clear environmental causes or lifestyle factors have been linked to the condition.
Key Symptoms: Bone pain that may increase with activity or over time. Bone deformities, including uneven growth, bowing, or abnormal shapes. Swelling or palpable lumps over affected bones. Fractures that can occur easily due to weakened bones. Possible skin changes or freckles in cases associated with syndromes like McCune-Albright. In some cases, limited joint movement if joints are involved.
Diagnostic & Treatment
Diagnosis Path: Diagnosing polyostotic fibrous dysplasia typically involves a combination of clinical evaluation and imaging tests. Key diagnostic steps include: - **Medical History and Physical Examination:** Evaluation of symptoms, bone deformities, and skin findings. - **X-rays:** To identify characteristic areas of radiolucent, ground-glass appearance in the affected bones. - **Bone Scans:** To assess the extent of bone involvement throughout the skeleton. - **MRI or CT scans:** For detailed imaging of bone and soft tissue. - **Biopsy:** Occasionally performed to confirm the diagnosis by examining a sample of affected bone tissue. - **Genetic testing:** May be used to identify mutations in the GNAS gene, especially in atypical or ambiguous cases.
Treatment Protocols: Management of polyostotic fibrous dysplasia focuses on alleviating symptoms, preventing complications, and monitoring disease progression. Typical approaches include: - **Pain Management:** Use of analgesics to control discomfort. - **Surgical Intervention:** Corrective surgeries may be performed to stabilize bones, correct deformities, or address fractures. - **Bisphosphonates:** Medications that may help strengthen bone and reduce pain, although their effectiveness varies. - **Monitoring:** Regular imaging and clinical assessments to track changes over time. - **Addressing Associated Conditions:** Managing skin changes or hormonal imbalances if related to syndromes like McCune-Albright. - **Physical Therapy:** To support mobility and maintain function.
Clinical Advice & FAQs
Billing Guidance
Is Q78.1 a billable ICD-10 code?
Yes, Q78.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q78.1?
Clinical documentation must specify the nature of Polyostotic fibrous dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference